Nuclear receptor ROR-beta — Drug Target

All drugs that target Nuclear receptor ROR-beta — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Retinoid [EPC]

Marketed (1)

• Retin-A · Bausch Health · Retinoid [EPC] · Oncology
  Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation.